Skip to Content
Merck
  • Enrofloxacin oxidative degradation facilitated by metal oxide nanoparticles.

Enrofloxacin oxidative degradation facilitated by metal oxide nanoparticles.

Chemosphere (2011-11-08)
Lea Fink, Ishai Dror, Brian Berkowitz
ABSTRACT

The activity of copper oxide, titanium carbide and silicon nitride nanoparticles for the oxidative degradation of environmentally relevant concentrations (μg L(-1) range) of enrofloxacin - an important veterinary antibiotic drug - in aqueous solutions was investigated. With hydrogen peroxide as an oxidative agent, both copper oxide and titanium carbide decrease the concentration of enrofloxacin by more than 90% over 12 h. Addition of sodium halide salts strongly increases the reaction rate of copper oxide nanoparticles. The mechanism for the formation of Reactive Oxygen Species (ROS) was investigated by Electron Spin Resonance (ESR).

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Titanium(IV) carbide, powder, <4 μm, ≥99% (Ti)
Sigma-Aldrich
Titanium(IV) carbide, −325 mesh, 98%
Sigma-Aldrich
Titanium carbide, nanopowder, ≤200 nm particle size (SEM)